Catalyst Wire Dossier Catalyst Wire Dossier

Ag85B-ESAT-6 TB subunit vaccine

Tuberculosis subunit vaccine (Ag85B-ESAT-6) · Statens Serum Institut
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ag85B-ESAT-6 TB subunit vaccine, covering 2013-01-21 to 2013-01-21. Get the full timeline:

Most recent: Clinical Trial Update: Trial on the Safety of a New Liposomal Adjuvant System, CAF01, When Given With the Tuberculosis Subunit Vaccine Ag85B-ESAT-6 as Two Injections With Two Months Interval to Healthy Adult Volunteers [Phase 1]

See pricing